HOME >> MEDICINE >> NEWS
U.S.-Russian team announces breakthrough in fight against tuberculosis

Arlington, VA September 28, 2002 - U.S and Russian researchers announced today a major development in their joint efforts to find a treatment for drug-resistant tuberculosis at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Diego.

Since 2000, with funding from the U.S. Civilian Research and Development (CRDF), Cynthia Tuthill, Ph.D. of SciClone Pharmaceuticals, Inc., a biopharmaceutical company in San Mateo, California, and Alexander Kolobov, Ph.D. of Verta, Ltd., a biotech company in St. Petersburg, Russia, have been leading a team of scientists in pioneering clinical research with SCV-07, an immune-stimulating compound the scientists anticipate will lead to the production of an oral treatment for drug-resistant tuberculosis.

Alexander Kolobov presented evidence at the conference that Russian hospital patients who participated in the SCV-07 clinical trials showed a marked decrease in the presence of tuberculosis in the lungs. The patients also showed a significant reduction in ailments symptomatic of tuberculosis, such as fever, chest pain, and dry coughing.

The announcement is viewed as a milestone by the CRDF as the project is a successful example of what the foundation promotes: mutually beneficial scientific collaboration between U.S. industry and scientists and engineers and researchers from the former Soviet Union.

"Verta researchers have been investigating immune-stimulating compounds as a possible treatment for tuberculosis and our Russian partners brought with them an expertise that allowed us to move testing into the clinical stage much faster than would have otherwise been possible," said Cynthia Tuthill, on the benefits of teaming with Verta.

The project is also significant for its contribution to the CRDF's work to redirect former Soviet defense researchers to civilian employ in support of U.S. nonproliferation efforts. "In funding U.S. and former Soviet collaborative
'"/>

Contact: Chantal Guess
cguess@crdf.org
703-526-6746
U.S. Civilian Research and Development Foundation
28-Sep-2002


Page: 1 2

Related medicine news :

1. The Gerontological Society of America announces Hartford Fellowship recipients
2. TB Alliance announces new drug discovery program with GlaxoSmithKline
3. ASGE announces grant recipients in annual research awards program
4. Novartis announces collaboration with Bayer for EMSELEX
5. American College of Chest Physicians announces new Critical Care Institute
6. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
7. Department of Energy announces new agreement with USC, national labs and private company
8. ACP announces international medical fellowship
9. St. Jude Medical announces CRT patients showed improvement in the RHYTHM ICD study
10. St. Jude Medical announces PAVE and DINAMIT clinical trial results
11. National Inventors Hall of Fame announces 2004 class of inventors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/13/2019)... ... ... The American Med Spa Association (AmSpa) has released the 2019 Medical Spa State of ... professionals understand the realities of the industry and make better, more informed decisions using ... released the 2017 Medical Spa State of the Industry Report and so much has ...
(Date:7/11/2019)... ... July 11, 2019 , ... ... tools and educational resources with a range of features to further advance their ... global pharmaceutical industry in manufacturing quality medicines for patients worldwide. The latest additions ...
(Date:7/10/2019)... ... July 10, 2019 , ... HMP, a leader in ... partner of the Oncology Clinical Pathways Congress, taking place October 11-13, 2019 in Boston. ... Clinical Pathways and focuses on the expansion of clinical pathways as a decision support ...
(Date:7/9/2019)... ... ... offer laser vaginal rejuvenation. Laser vaginal rejuvenation gives women a less painful and effective solution ... , vaginal dryness and burning , vaginal atrophy , ... imbalances , recurrent vaginal infections , vaginal and vulvar itching , ...
(Date:7/9/2019)... Md. (PRWEB) , ... July 09, 2019 , ... A2LA ... testing, specifically for hemp plant material, oils, and solids. GEL Laboratories is based in ... GEL Laboratories is also the first laboratory in the field of environmental testing ...
Breaking Medicine News(10 mins):
(Date:7/13/2019)... ... ... Meet the Pettys, Will and Jamie Petty met in 2011 and soon became inseparable. They ... just six months later. , For the next three years Will and Jamie grew as ... In 2015 the decision was made to begin the process of trying. After several years ...
(Date:7/11/2019)... ... 11, 2019 , ... N1-Headache, the only digital health platform ... four abstracts at the 61st Annual Scientific Meeting of the American Headache ... in people with chronic migraine. (1-4) , Ken Shulman, D.O., V.P. Medical Affairs ...
(Date:7/11/2019)... , ... July 11, 2019 , ... ... has recently created products in line with TSA guidelines for domestic airline flights. ... 2019, the TSA changed its guidelines to allow some forms of ...
Breaking Medicine Technology:
Cached News: